HIV-1 envelope determinants for cell tropism and chemokine receptor use - PubMed (original) (raw)
Review
. 1999 Jan-Mar;16(1):57-65.
doi: 10.1080/096876899294760.
Affiliations
- PMID: 10332738
- DOI: 10.1080/096876899294760
Review
HIV-1 envelope determinants for cell tropism and chemokine receptor use
T L Hoffman et al. Mol Membr Biol. 1999 Jan-Mar.
Abstract
Isolates of human immunodeficiency virus type-1 (HIV-1) display marked differences in their ability to replicate in macrophages and transformed T-cell lines in vitro, a property that has important implications for disease pathogenesis. The restriction in replication between these two CD4-positive cell types is largely at the level of viral entry and is regulated by the viral envelope (env) gene. The envelope protein (Env) is responsible for fusion of the viral and host membranes, and a particular region of Env called the V3-loop has been implicated in regulating viral tropism. However, other regions of Env, such as the V1- and V2-loops, have been shown to modulate the effects of the V3-loop. The discovery that Env initially binds the CD4 molecule on the target cell surface and then makes subsequent interactions with one of several members of the chemokine receptor family has greatly enhanced the molecular understanding of HIV-1 entry. The differential use of chemokine receptors by different viral isolates and their expression in different cell types largely explains viral tropism. The same regions in Env responsible for virus tropism have also been shown to play an important role in mediating chemokine receptor use. The recent crystallization of HIV-1 Env in complex with CD4 illuminates the architecture of the components involved in mediating fusion between the viral and host membranes. The spatial relationship between variable structures of Env previously implicated in tropism and chemokine receptor use and conserved Env structures potentially involved in chemokine receptor binding are discussed.
Similar articles
- The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
Rossi F, Querido B, Nimmagadda M, Cocklin S, Navas-Martín S, Martín-García J. Rossi F, et al. Retrovirology. 2008 Oct 6;5:89. doi: 10.1186/1742-4690-5-89. Retrovirology. 2008. PMID: 18837996 Free PMC article. - HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW, Morrison O, Vassell R, Weiss CD. Keller PW, et al. J Virol. 2018 Jul 31;92(16):e00583-18. doi: 10.1128/JVI.00583-18. Print 2018 Aug 15. J Virol. 2018. PMID: 29875245 Free PMC article. - Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
Toohey K, Wehrly K, Nishio J, Perryman S, Chesebro B. Toohey K, et al. Virology. 1995 Oct 20;213(1):70-9. doi: 10.1006/viro.1995.1547. Virology. 1995. PMID: 7483281 - Structural interactions between chemokine receptors, gp120 Env and CD4.
Choe H, Martin KA, Farzan M, Sodroski J, Gerard NP, Gerard C. Choe H, et al. Semin Immunol. 1998 Jun;10(3):249-57. doi: 10.1006/smim.1998.0127. Semin Immunol. 1998. PMID: 9653051 Review. - The SIV Envelope Glycoprotein, Viral Tropism, and Pathogenesis: Novel Insights from Nonhuman Primate Models of AIDS.
Swanstrom AE, Del Prete GQ, Deleage C, Elser SE, Lackner AA, Hoxie JA. Swanstrom AE, et al. Curr HIV Res. 2018;16(1):29-40. doi: 10.2174/1570162X15666171124123116. Curr HIV Res. 2018. PMID: 29173176 Review.
Cited by
- Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors.
Lungu C, Overmars RJ, Grundeken E, Boers PHM, van der Ende ME, Mesplède T, Gruters RA. Lungu C, et al. Viruses. 2023 Nov 9;15(11):2236. doi: 10.3390/v15112236. Viruses. 2023. PMID: 38005913 Free PMC article. - Virus-Induced Cell Fusion and Syncytia Formation.
Xie M. Xie M. Results Probl Cell Differ. 2024;71:283-318. doi: 10.1007/978-3-031-37936-9_14. Results Probl Cell Differ. 2024. PMID: 37996683 - Human Mannose Receptor 1 Attenuates HIV-1 Infectivity in a Virus Isolate-Specific Manner.
Saito H, Sukegawa S, Kao S, Strebel K. Saito H, et al. Viruses. 2023 Oct 6;15(10):2057. doi: 10.3390/v15102057. Viruses. 2023. PMID: 37896833 Free PMC article. - The Emerging Role of the Serine Incorporator Protein Family in Regulating Viral Infection.
Xu S, Zheng Z, Pathak JL, Cheng H, Zhou Z, Chen Y, Wu Q, Wang L, Zeng M, Wu L. Xu S, et al. Front Cell Dev Biol. 2022 Apr 1;10:856468. doi: 10.3389/fcell.2022.856468. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35433679 Free PMC article. Review. - Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice.
Alteri C, Scutari R, Bertoli A, Armenia D, Gori C, Fabbri G, Mastroianni CM, Cerva C, Cristaudo A, Vicenti I, Bruzzone B, Zazzi M, Andreoni M, Antinori A, Svicher V, Ceccherini-Silberstein F, Perno CF, Santoro MM. Alteri C, et al. Virus Genes. 2019 Jun;55(3):290-297. doi: 10.1007/s11262-019-01649-z. Epub 2019 Feb 22. Virus Genes. 2019. PMID: 30796743
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials